Stem cell therapy for osteonecrosis of the femoral head

Bibliography

• LIEBERMAN JR, BERRY DJ, MONT MA et al.: Osteonecrosis of the hip: management in the 21st century. J. Bone Joint Surg. Am. (2003) 52:337–355.
   Google Scholar
• STEINBERG ME, LARCOM PG, STAFFORD BB et al.: Treatment of osteonecrosis of the femoral head by core decompression, bone grafting and electrical stimulation. In: Osteonecrosis: Etiology, Diagnosis and Treatment. Urbaniak JR, Jones JP Jr (Eds), Academy of Orthopaedic Surgeons. Rosemont, IL, USA (1997):293–299.
   Google Scholar
• KOO KH, KIM R, KO GH, SONG HR, JEONG ST, CHO SH: Preventing collapse in early osteonecrosis of the femoral head. A randomised clinical trial of core decompression./ Bone Joint Surg. Br. (1995) 77(6):870–874.
   Google Scholar
• STULBERG BN, DAVIS AW, BAUER TW, LEVINE M, EASLEY K: Osteonecrosis of the femoral head. A prospective randomized treatment protocol. Clin. Orthop. Relat. Res. (1991) 268:140–151.
   PubMedGoogle Scholar
• JONES JP JR: Fat embolism and osteonecrosis. Orthop. Clin. North Am. (1985) 16(4):595–633.
   PubMed Web of Science ®Google Scholar
• WANG GJ, SWEET DE, REGER SI, THOMPSON RC: Fat-cell changes as a mechanism of avascular necrosis of the femoral head in cortisone-treated rabbits. J. Bone Joint Surg. Am. (1977) 59(0:729–735.
   PubMedGoogle Scholar
• SIMKIN PA, DOWNEY DJ: Hypothesis: retrograde embolization of marrow fat may cause osteonecrosis. J. RheumatoL (1987) 14(5):870–872.
   PubMed Web of Science ®Google Scholar
• GLUECK CJ, FREIBERG RA, FONTAINE RN, TRACY T, WANG P: Hypofibrinolysis, thrombophilia, osteonecrosis. Clin. Orthop. Relat. Res. (2001) 386:19–33.
   PubMed Web of Science ®Google Scholar
• HERNIGOU P, BEAUJEAN F, LAMBOTTE JC: Decrease in the mesenchymal stem-cell pool in the proximal femur in corticosteroid-induced osteonecrosis. J. Bone Joint Surg Br. (1999) 81(2):349–355.
   PubMedGoogle Scholar
• •First paper to describe the potential role of mesenchymal stem cells in the pathophysiology of ON.
   Google Scholar
• GANGJI V, HAUZEUR JP, SCHOUTENS A, HINSENKAMP M, APPELBOOM T, EGRISE D: Abnormalities in the replicative capacity of osteoblastic cells in the proximal femur of patients with osteonecrosis of the femoral head. J. RheumatoL (2003) 30(2):348–351.
   PubMed Web of Science ®Google Scholar
• •First paper to describe a potential role for the osteoblastic cell in the pathophysiology of ON.
   Google Scholar
• SOTTILE V, THOMSON A, MCWHIR J: In vitro osteogenic differentiation of human ES cells. Cloning Stem Cells (2003) 5(2):149–155.
   PubMedGoogle Scholar
• SLACK JM: Stem cells in epithelial tissues. Science (2000) 287(5457):1431–1433.
   PubMed Web of Science ®Google Scholar
• WEISSMAN IL: Stem cells: units of development, units of regeneration, and units in evolution. Cell (2000) 100(1):157–168.
   PubMed Web of Science ®Google Scholar
• BLAU HM, BRAZELTON TR, WEIMANN JM: The evolving concept of a stem cell: entity or function? Cell (2001) 105(7):829–841.
   PubMed Web of Science ®Google Scholar
• •Review on stem cells as a function.
   Google Scholar
• HERZOG EL, CHAT L, KRAUSE DS: Plasticity of marrow-derived stem cells. Blood (2003) 102(10):3483–3493.
   PubMed Web of Science ®Google Scholar
• KORBLING M, KATZ RL, KHANNA A et al.: Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells. N EngL J. Med. (2002) 346(10):738–746.
   PubMed Web of Science ®Google Scholar
• HORWITZ EM, PROCKOP DJ, FITZPATRICK LA et al.: Transplantability and therapeutic effects of bone marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat. Med. (1999) 5(3):309–313.
   PubMed Web of Science ®Google Scholar
• •First report on the efficacy of mesenchymal cell transplantation in a bone disease.
   Google Scholar
• HORWITZ EM, GORDON PL, KOO WK et al.: Isolated allogeneic bone marrow-derived mesenchymal cells engraft and stimulate growth in children with osteogenesis imperfecta: implications for cell therapy of bone. Proc. NatL Acad. Sci. USA (2002) 99(13):8932–8937.
   PubMed Web of Science ®Google Scholar
• ASAHARA T, MUROHARA T, SULLIVAN A et al.: Isolation of putative progenitor endothelial cells for angiogenesis. Science (1997) 275:964–967.
   PubMed Web of Science ®Google Scholar
• SHI Q, RAFII S, WU MH et aL: Evidence for circulating bone marrow-derived endothelial cells. Blood (1998) 92(2):362–367.
   PubMed Web of Science ®Google Scholar
• KOCHER AA, SCHUSTER MD, SZABOLCS MJ et al.: Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. (2001) 7(0430–436.
   PubMed Web of Science ®Google Scholar
• KINNAIRD T, STABILE E, BURNETT MS et al.: Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. (2004) 94(5):678–685.
   PubMed Web of Science ®Google Scholar
• REHMAN J, LI J, ORSCHELL CM, MARCH KL: Peripheral blood 'endothelial progenitor cells' are derived from Monocyte/macrophages and secrete angiogenic growth factors. Circulation (2003) 107(8):1164–1169.
   PubMed Web of Science ®Google Scholar
• ZIEGELHOEFFER T, FERNANDEZ B, KOSTIN S et al.: Bone marrow-derived cells do not incorporate into the adult growing vasculature. Circ. Res. (2004) 94(2):230–238.
   PubMed Web of Science ®Google Scholar
• SHYU KG, MANOR 0, MAGNER M, YANCOPOULOS GD, ISNER JM: Direct intramuscular injection of plasmid DNA encoding angiopoietin-1 but not angiopoietin-2 augments revascularization in the rabbit ischemic hindlimb. Circulation (1998) 98(19):2081–2087.
   PubMed Web of Science ®Google Scholar
• HERNIGOU P, BERNAUDIN F, REINERT P, KUENTZ M, VERNANT JP: Bone-marrow transplantation in sickle-cell disease. Effect on osteonecrosis: a case report with a four-year follow-up. J. Bone Joint Surg. Am. (1997) 79(11):1726–1730.
   PubMedGoogle Scholar
• •First report of bone marrow transplantation in ON.
   Google Scholar
• HAUZEUR JP, ORLOFF S, TAVERNE-VERBANCK J, PASTEELS JL: Diagnosis of aseptic osteonecrosis of the femoral head by percutaneous transtrochanterian needle biopsy. Clin. Rheumatol. (1986) 5(3):346–358.
   PubMed Web of Science ®Google Scholar
• HAUZEUR JP, SINTZOFF S JR, APPELBOOM T, DE MAERTELAER BENTIN J, PASTEELS JL: Relationship between magnetic resonance imaging and histologic findings by bone biopsy in nontraumatic osteonecrosis of the femoral head./ RheumatoL (1992) 19(3):385–392.
   PubMed Web of Science ®Google Scholar
• GANGJI V HAUZEUR JP, MATOS C, DE MAERTELAER V, TOUNGOUZ M, LAMBERMONT M: Treatment of osteonecrosis of the femoral head with implantation of autologous bone-marrow cells. A pilot study. J. Bone Joint Surg Am. (2004) 86-A(6):1153–1160.
   Google Scholar
• •First controlled, double-blind trial on the efficacy of bone marrow implantation in ON.
   Google Scholar
• HERNIGOU P, BEAUJEAN F: Treatment of osteonecrosis with autologous bone marrow grafting. Clin. Orthop. Relat. Res. (2002) 405:14–23.
   PubMed Web of Science ®Google Scholar
• •First prospective study on the efficacy of bone marrow implantation in ON.
   Google Scholar
• STAMM C, WESTPHAL B, KLEINE HD et al.: Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet (2003) 361:45–46.
   PubMed Web of Science ®Google Scholar
• STRAUER BE, BREHM M, ZEUS T et al.: Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation (2002) 106(15):1913–1918.
   PubMed Web of Science ®Google Scholar
• TSE HF, KWONG YL, CHAN JK, LO G, HO CL, LAU CP: Angiogenesis in ischaemic myocardium by intramyocardial autologous bone marrow mononuclear cell implantation. Lancet (2003) 361:47–49.
   PubMed Web of Science ®Google Scholar
• TATEISHI-YUYAMA E, MATSUBARA H, MUROHARA T et aL: Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet (2002) 360:427–435.
   PubMed Web of Science ®Google Scholar